<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9764907" created="04/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9764907</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Potent inhibition of <term id="T1" lex="HIV_type_1_replication" sem="Other"><term id="T2" lex="HIV_type_1" sem="Virus">HIV type 1</term> replication</term> by an <term id="T3" lex="antiinflammatory_alkaloid" sem="Organic_compound_other">antiinflammatory alkaloid</term>, <term id="T4" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term>, in <term id="T5" lex="chronically_infected_monocytic_cell" sem="Cell_natural">chronically infected monocytic cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Viral_life_cycle"/>
<theme idref="T2"/>
<clue>Potent inhibition of HIV type 1 <clueType>replication</clueType> by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.</clue>
</event>
<event KT="Investigation" Manner="High" id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue><clueManner>Potent</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> HIV type 1 replication <linkCause>by</linkCause> an antiinflammatory alkaloid, cepharanthine, <clueLoc>in chronically infected monocytic cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="cepharanthine" sem="Organic_compound_other">Cepharanthine</term> is a <term id="T7" lex="biscoclaurine_alkaloid" sem="Organic_compound_other">biscoclaurine alkaloid</term> isolated from <term id="T8" lex="Stephania_cepharantha_Hayata" sem="Multicellular_organism_natural">Stephania cepharantha Hayata</term> and has been shown to have antiinflammatory, antiallergic, and immunomodulatory activities in vivo.</sentence>
<sentence id="S3">As several <term id="T9" lex="inflammatory_cytokine" sem="Protein_family_or_group">inflammatory <term id="T10" lex="cytokine" sem="Protein_family_or_group">cytokines</term></term> and <term id="A2" sem="Other">oxidative stresses</term> are involved in the <term id="A12" sem="Other">pathogenesis</term> of <term id="T11" lex="HIV-1_infection" sem="Other"><term id="A1" sem="Virus">HIV-1</term> infection</term>, we investigated the inhibitory effects of <term id="T12" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term> on <cons id="T13" lex="(AND tumor_necrosis_factor_alpha_(TNF-alpha)-induced_HIV-1_replication phorbol_12-myristate_13-acetate_(PMA)-induced_HIV-1_replication)" sem="(AND Other Other)"><frag id="F1">tumor necrosis factor alpha (<term id="T14" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>)-</frag> and <frag id="F2">phorbol 12-myristate 13-acetate (<term id="T15" lex="PMA" sem="Organic_compound_other">PMA</term>)-</frag><frag id="F3">induced <term id="A3" sem="Virus">HIV-1</term> replication</frag></cons> in <term id="T16" lex="chronically_infected_cell_line" sem="Cell_cultured">chronically infected cell lines</term>.</sentence>
<event KT="Other" id="E3">
<type class="Initiation_of_viral_infection"/>
<theme idref="A1"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 <clueType>infection</clueType>, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="A12"/>
<cause idref="T9"/>
<clue>As several inflammatory cytokines and oxidative stresses are <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Other" id="E40">
<type/>
<theme idref="E3"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="A12"/>
<cause idref="A2"/>
<clue>As several inflammatory cytokines and oxidative stresses are <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T14"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-<clueType>induced</clueType> HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T14"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-<clueType>induced</clueType> HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Other" id="E7">
<type class="Viral_life_cycle"/>
<theme idref="A3"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we investigated the inhibitory effects of cepharanthine on tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 <clueType>replication</clueType> <clueLoc>in chronically infected cell lines</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T12"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we <clueKT>investigated</clueKT> the <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T12"/>
<clue>As several inflammatory cytokines and oxidative stresses are involved in the pathogenesis of HIV-1 infection, we <clueKT>investigated</clueKT> the <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> tumor necrosis factor alpha (TNF-alpha)- and phorbol 12-myristate 13-acetate (PMA)-induced HIV-1 replication in chronically infected cell lines.</clue>
</event>
<sentence id="S4">Two <term id="T17" lex="chronically_HIV-1-infected_cell_line" sem="Cell_cultured">chronically <term id="T18" lex="HIV-1" sem="Virus">HIV-1</term>-infected cell lines</term>, <term id="T19" lex="U1" sem="Cell_cultured">U1</term> (monocytic) and <term id="T20" lex="ACH-2" sem="Cell_cultured">ACH-2</term> (T lymphocytic), were stimulated with <term id="T21" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> or <term id="T22" lex="PMA" sem="Organic_compound_other">PMA</term> and cultured in the presence of various concentrations of the compound.</sentence>
<event id="E10">
<type class="Physiological_process"/>
<theme idref="T19"/>
<cause idref="T21"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E11">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="T21"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E12">
<type class="Physiological_process"/>
<theme idref="T19"/>
<cause idref="T22"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event id="E13">
<type class="Physiological_process"/>
<theme idref="T20"/>
<cause idref="T22"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were <clueType>stimulated</clueType> <linkCause>with</linkCause> TNF-alpha or PMA and cultured in the presence of various concentrations of the compound.</clue>
</event>
<event KT="Method" id="E34">
<type class="Artificial_process"/>
<theme idref="E10"/>
<theme idref="T12"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event KT="Method" id="E35">
<type class="Artificial_process"/>
<theme idref="E11"/>
<theme idref="T12"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event KT="Method" id="E36">
<type class="Artificial_process"/>
<theme idref="E12"/>
<theme idref="T12"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<event KT="Method" id="E37">
<type class="Artificial_process"/>
<theme idref="E13"/>
<theme idref="T12"/>
<clue>Two chronically HIV-1-infected cell lines, U1 (monocytic) and ACH-2 (T lymphocytic), were stimulated with TNF-alpha or PMA and <clueType>cultured</clueType> <linkTheme>in the presence of</linkTheme> various concentrations of <corefTheme>the compound</corefTheme>.</clue>
</event>
<sentence id="S5"><term id="T23" lex="HIV-1_replication" sem="Other"><term id="T24" lex="HIV-1" sem="Virus">HIV-1</term> replication</term> was determined by <term id="T25" lex="p24_antigen_level" sem="Other"><term id="T26" lex="p24_antigen" sem="Protein_molecule">p24 antigen</term> level</term>.</sentence>
<event KT="Analysis" id="E14">
<type class="Viral_life_cycle"/>
<theme idref="T24"/>
<clue>HIV-1 <clueType>replication</clueType> was <clueKT>determined</clueKT> by p24 antigen level.</clue>
</event>
<event KT="Other" id="E33" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>HIV-1 replication was determined by p24 antigen <clueType>level</clueType>.</clue>
</event>
<sentence id="S6">The inhibitory effects of <term id="T27" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term> on <term id="T29" lex="HIV-1_long_terminal_repeat" sem="DNA_domain_or_region"><term id="T30" lex="HIV-1" sem="Virus">HIV-1</term> long terminal repeat</term> (<term id="T31" lex="LTR" sem="DNA_domain_or_region">LTR</term>)-driven <term id="A10" sem="Other">gene expression</term> and <term id="T32" lex="nuclear_factor_kappaB_(NF-kappaB)_activation" sem="Other"><term id="T33" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T34" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>) activation</term> were also examined.</sentence>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T27"/>
<clue>The <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) activation were also <clueKT>examined</clueKT>.</clue>
</event>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="T27"/>
<clue>The <clueType>inhibitory effects</clueType> <linkCause>of</linkCause> cepharanthine <linkTheme>on</linkTheme> HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) activation were also <clueKT>examined</clueKT>.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="A10"/>
<cause idref="T31"/>
<clue>The inhibitory effects of cepharanthine on HIV-1 long terminal repeat (LTR)-<clueType>driven</clueType> gene expression and nuclear factor kappaB (NF-kappaB) activation were also examined.</clue>
<comment>NER: T28 del &quot;HIV-1 long terminal repeat (LTR)-driven gene expression&quot;</comment></event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T34"/>
<clue>The inhibitory effects of cepharanthine on HIV-1 long terminal repeat (LTR)-driven gene expression and nuclear factor kappaB (NF-kappaB) <clueType>activation</clueType> were also examined.</clue>
</event>
<sentence id="S7"><term id="T35" lex="cepharanthine" sem="Organic_compound_other">Cepharanthine</term> dose dependently inhibited <term id="T36" lex="HIV-1_replication" sem="Other"><term id="T37" lex="HIV-1" sem="Virus">HIV-1</term> replication</term> in <cons id="T38" lex="(AND TNF-alpha-stimulated_U1_cell PMA-stimulated_U1_cell)" sem="(AND Cell_cultured Cell_cultured)"><frag id="F4"><term id="A4" sem="Protein_molecule">TNF-alpha</term>-</frag> and <frag id="F5"><term id="A5" sem="Organic_compound_other">PMA</term>-</frag><frag id="F6">stimulated <term id="A6" sem="Cell_cultured">U1 cells</term></frag></cons> but not in <term id="T39" lex="ACH-2_cell" sem="Cell_cultured">ACH-2 cells</term>.</sentence>
<event KT="Other" id="E19">
<type class="Viral_life_cycle"/>
<theme idref="T37"/>
<clue>Cepharanthine dose dependently inhibited HIV-1 <clueType>replication</clueType> in TNF-alpha- and PMA-stimulated U1 cells but not in ACH-2 cells.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T35"/>
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication <clueLoc>in TNF-alpha-</clueLoc> and PMA-<clueLoc>stimulated U1 cells</clueLoc> but not in ACH-2 cells.</clue>
</event>
<event id="E39">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T35"/>
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication <clueLoc>in</clueLoc> TNF-alpha- and <clueLoc>PMA-stimulated U1 cells</clueLoc> but not in ACH-2 cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T35"/>
<clue>Cepharanthine dose dependently <clueType>inhibited</clueType> HIV-1 replication in TNF-alpha- and PMA-stimulated U1 cells but <cluePolarity>not</cluePolarity> <clueLoc>in ACH-2 cells</clueLoc>.</clue>
</event>
<event id="E22">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="A4"/>
<clue>Cepharanthine dose dependently inhibited HIV-1 replication in TNF-alpha- and PMA-<clueType>stimulated</clueType> U1 cells but not in ACH-2 cells.</clue>
</event>
<event id="E23">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="A5"/>
<clue>Cepharanthine dose dependently inhibited HIV-1 replication in TNF-alpha- and PMA-<clueType>stimulated</clueType> U1 cells but not in ACH-2 cells.</clue>
</event>
<sentence id="S8">Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in <term id="T40" lex="PMA-stimulated_U1_cell" sem="Cell_cultured"><term id="T41" lex="PMA" sem="Organic_compound_other">PMA</term>-stimulated <term id="A7" sem="Cell_cultured">U1 cells</term></term>, respectively.</sentence>
<event id="E24">
<type class="Physiological_process"/>
<theme idref="A7"/>
<cause idref="T41"/>
<clue>Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-<clueType>stimulated</clueType> U1 cells, respectively.</clue>
</event>
<sentence id="S9"><term id="T42" lex="cepharanthine" sem="Organic_compound_other">Cepharanthine</term> was found to suppress <term id="T44" lex="HIV-1_LTR" sem="DNA_domain_or_region"><term id="T45" lex="HIV-1" sem="Virus">HIV-1</term> LTR</term>-driven <term id="A11" sem="Other">gene expression</term> through the inhibition of <term id="T46" lex="NF-kappaB_activation" sem="Other"><term id="T47" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term>.</sentence>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T42"/>
<clue>Cepharanthine was found to suppress HIV-1 LTR-driven gene expression through the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappaB activation.</clue>
</event>
<event KT="Other" id="E26">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<clue>Cepharanthine was found to suppress HIV-1 LTR-driven gene expression through the inhibition of NF-kappaB <clueType>activation</clueType>.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="E25"/>
<clue>Cepharanthine was <clueKT>found</clueKT> to <clueType>suppress</clueType> HIV-1 LTR-driven gene expression <linkCause>through</linkCause> the inhibition of NF-kappaB activation.</clue>
</event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="A11"/>
<cause idref="T44"/>
<clue>Cepharanthine was found to suppress HIV-1 LTR-<clueType>driven</clueType> gene expression through the inhibition of NF-kappaB activation.</clue>
<comment>NER: T43 del &quot;HIV-1 LTR-driven gene expression&quot;</comment></event>
<sentence id="S10">These results indicate that <term id="T48" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term> is a highly potent inhibitor of <term id="T49" lex="HIV-1_replication" sem="Other"><term id="T50" lex="HIV-1" sem="Virus">HIV-1</term> replication</term> in a <term id="T51" lex="chronically_infected_monocytic_cell_line" sem="Cell_cultured">chronically infected <term id="A8" sem="Cell_cultured">monocytic cell line</term></term>.</sentence>
<event KT="Other" id="E29">
<type class="Viral_life_cycle"/>
<theme idref="T50"/>
<clue>These results indicate that cepharanthine is a highly potent inhibitor of HIV-1 <clueType>replication</clueType> <clueLoc>in a chronically infected monocytic cell line</clueLoc>.</clue>
</event>
<event KT="Other" id="E30">
<type class="Initiation_of_viral_infection"/>
<theme idref="A8"/>
<theme idref="T50"/>
<clue>These results indicate that cepharanthine is a highly potent inhibitor of HIV-1 replication in a chronically <clueType>infected</clueType> monocytic cell line.</clue>
</event>
<event CL="L2" KT="Analysis" Manner="High" id="E31">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T48"/>
<clue>These results <clueKT><clueCL>indicate</clueCL></clueKT> that cepharanthine is a <clueManner>highly potent</clueManner> <clueType>inhibitor</clueType> <linkTheme>of</linkTheme> HIV-1 replication <clueLoc>in a chronically infected monocytic cell line</clueLoc>.</clue>
</event>
<sentence id="S11">Since <term id="T52" lex="biscoclaurine_alkaloid" sem="Organic_compound_other">biscoclaurine alkaloids</term>, containing <term id="T53" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term> as a major component, are widely used for the treatment of patients with various <term id="T54" lex="inflammatory_disease" sem="Other">inflammatory diseases</term> in Japan, <term id="T55" lex="cepharanthine" sem="Organic_compound_other">cepharanthine</term> should be further pursued for its <term id="T56" lex="chemotherapeutic_potential" sem="Other">chemotherapeutic potential</term> in <term id="T57" lex="HIV-1-infected_patient" sem="Multicellular_organism_natural"><term id="T58" lex="HIV-1" sem="Virus">HIV-1</term>-infected <term id="A9" sem="Multicellular_organism_natural">patients</term></term>.</sentence>
<event CL="L1" KT="Analysis" id="E32">
<type class="Initiation_of_viral_infection"/>
<theme idref="A9"/>
<theme idref="T58"/>
<clue>Since biscoclaurine alkaloids, containing cepharanthine as a major component, are widely used for the treatment of patients with various inflammatory diseases in Japan, cepharanthine should be further pursued for its chemotherapeutic <clueKT><clueCL>potential</clueCL></clueKT> in HIV-1-<clueType>infected</clueType> patients.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
